Immunocompetence may be important in the effectiveness of Mectizan® (ivermectin) in the treatment of human onchocerciasis
- 14 June 2002
- journal article
- clinical trial
- Published by Elsevier in Acta Tropica
- Vol. 84 (1) , 49-53
- https://doi.org/10.1016/s0001-706x(02)00117-1
Abstract
No abstract availableKeywords
This publication has 4 references indexed in Scilit:
- What is the Real Target for Ivermectin Resistance Selection in Onchocerca volvulus?Parasitology Today, 2000
- Programmatic goals and approaches to onchocerciasisThe Lancet, 2000
- La résistance de Onchocerca volvulus à livermectine: une éventualité à considérerAnnales de l'Institut Pasteur / Actualités, 1999
- The effects of ivermectin on onchocercal skin disease and severe itching: results of a multicentre trialTropical Medicine & International Health, 1998